Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Biosciences, BioDiscovery Fine-tune CodeLink Software

NEW YORK, Jan. 16-Amersham Biosciences and BioDiscovery will jointly develop and commercialize software to analyze data generated by Amersham CodeLink microarrays, the two companies said today.

 

BioDiscovery, a specialty software company based in Marina del Rey, Calif., developed a software package for CodeLink when the microarray technology was owned by Motorola.

 

Amersham acquired the Motorola divisionin July 2002.

 

This partnership will help CodeLink users identify genes with weak expression signals, and simplifies the move to higher-density arrays, said Amersham.

 

For further information, see the statement.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.